As of Oct 21
| +0.01 / +0.44%|
The 7 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +119.30% increase from the last price of 2.28.
The current consensus among 9 polled investment analysts is to Hold stock in ImmunoGen Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.